Chi‐Kuan Ho

1.3k total citations
32 papers, 1.1k citations indexed

About

Chi‐Kuan Ho is a scholar working on Molecular Biology, Hematology and Immunology. According to data from OpenAlex, Chi‐Kuan Ho has authored 32 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 10 papers in Hematology and 10 papers in Immunology. Recurrent topics in Chi‐Kuan Ho's work include Immune Response and Inflammation (6 papers), Hematopoietic Stem Cell Transplantation (5 papers) and Retinoids in leukemia and cellular processes (4 papers). Chi‐Kuan Ho is often cited by papers focused on Immune Response and Inflammation (6 papers), Hematopoietic Stem Cell Transplantation (5 papers) and Retinoids in leukemia and cellular processes (4 papers). Chi‐Kuan Ho collaborates with scholars based in Taiwan, China and Japan. Chi‐Kuan Ho's co-authors include Hui‐Chi Hsu, Shengyuan Wang, Ming‐Ling Hsu, Ming‐Shi Shiao, Yuling Huang, Wen‐Hui Tsai, Hung Chiang, S. L. Law, Shur‐Jen Wang and Chiou‐Chung Yuan and has published in prestigious journals such as Cancer, Biochemical and Biophysical Research Communications and International Journal of Cancer.

In The Last Decade

Chi‐Kuan Ho

31 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chi‐Kuan Ho Taiwan 14 425 354 254 184 173 32 1.1k
Hui‐Chi Hsu Taiwan 16 350 0.8× 496 1.4× 149 0.6× 314 1.7× 207 1.2× 51 1.4k
Hyun‐Mee Oh South Korea 24 96 0.2× 585 1.7× 140 0.6× 51 0.3× 432 2.5× 55 1.4k
Shivaprasad H. Venkatesha United States 21 133 0.3× 639 1.8× 90 0.4× 118 0.6× 439 2.5× 31 1.6k
C Y Ho Hong Kong 11 88 0.2× 307 0.9× 90 0.4× 85 0.5× 725 4.2× 14 1.3k
Fujun Li China 20 115 0.3× 607 1.7× 55 0.2× 155 0.8× 186 1.1× 62 1.3k
Jin‐A Kim South Korea 18 96 0.2× 633 1.8× 426 1.7× 105 0.6× 66 0.4× 60 1.2k
Stéphane Barrette Canada 15 40 0.1× 388 1.1× 124 0.5× 146 0.8× 132 0.8× 26 967
Yuko Hirose Japan 20 148 0.3× 260 0.7× 112 0.4× 170 0.9× 190 1.1× 81 1.4k
Shirish Shukla India 18 97 0.2× 600 1.7× 130 0.5× 31 0.2× 133 0.8× 29 1.3k
Sarah Steer United Kingdom 6 46 0.1× 264 0.7× 97 0.4× 131 0.7× 106 0.6× 14 832

Countries citing papers authored by Chi‐Kuan Ho

Since Specialization
Citations

This map shows the geographic impact of Chi‐Kuan Ho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chi‐Kuan Ho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chi‐Kuan Ho more than expected).

Fields of papers citing papers by Chi‐Kuan Ho

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chi‐Kuan Ho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chi‐Kuan Ho. The network helps show where Chi‐Kuan Ho may publish in the future.

Co-authorship network of co-authors of Chi‐Kuan Ho

This figure shows the co-authorship network connecting the top 25 collaborators of Chi‐Kuan Ho. A scholar is included among the top collaborators of Chi‐Kuan Ho based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chi‐Kuan Ho. Chi‐Kuan Ho is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hsu, Hui‐Chi, Lo‐Chun Au, Chien‐Hui Lieu, et al.. (2004). Detection of bcr-abl gene expression at a low level in blood cells of some patients with essential thrombocythemia. Journal of Laboratory and Clinical Medicine. 143(2). 125–129. 12 indexed citations
2.
Ho, Chi‐Kuan, et al.. (2003). Moscatilin from the OrchidDendrobrium loddigesiiIs a Potential Anticancer Agent. Cancer Investigation. 21(5). 729–736. 50 indexed citations
3.
Tsai, Wen‐Hui, et al.. (2003). Parvovirus B19 infection in Taiwanese patients with hematological disorders. Journal of Medical Virology. 71(4). 605–609. 11 indexed citations
4.
Ho, Chi‐Kuan, et al.. (2002). Garcinone E, a Xanthone Derivative, has Potent Cytotoxic Effect Against Hepatocellular Carcinoma Cell Lines. Planta Medica. 68(11). 975–979. 129 indexed citations
5.
Hsu, Hui‐Chi, Wei‐Juin Su, Chang‐Yi Huang, et al.. (2002). Bone Marrow Samples From Patients With Aplastic Anemia Are Not Infected With Parvovirus B19 and. American Journal of Clinical Pathology. 117(1). 36–40. 11 indexed citations
7.
Hsu, Hui‐Chi, Ching‐Fen Yang, Kwang‐Jen Hsiao, et al.. (2001). Detection of Kaposi sarcoma-associated herpesvirus in bone marrow biopsy samples from patients with multiple myeloma. Cancer. 91(8). 1409–1413. 14 indexed citations
8.
Wang, Shengyuan, Ming‐Ling Hsu, Hui‐Chi Hsu, et al.. (2001). The Activity in ex vivo Expansion of Cord Blood Myeloid Progenitor Cells before and after Cryopreservation. Acta Haematologica. 105(1). 38–44. 8 indexed citations
9.
Ho, Chi‐Kuan, Lo‐Chun Au, Ho‐Jen Peng, & Shengyuan Wang. (2001). Transforming growth factor beta may act as an autocrine-survival-promoting factor for transformed trophoblasts. In Vitro Cellular & Developmental Biology - Animal. 37(4). 245–250. 1 indexed citations
11.
Hsu, Hui‐Chi, et al.. (1999). Circulating levels of thrombopoietic and inflammatory cytokines in patients with clonal and reactive thrombocytosis. Journal of Laboratory and Clinical Medicine. 134(4). 392–397. 65 indexed citations
12.
Ho, Chi‐Kuan, et al.. (1998). Tamoxifen-mediated anti-cellular effect against a choriocarcinoma cell line.. International Journal of Oncology. 12(5). 1171–6. 4 indexed citations
13.
Wang, Shengyuan, et al.. (1997). The anti-tumor effect of Ganoderma Lucidum is mediated by cytokines released from activated macrophages and T lymphocytes. International Journal of Cancer. 70(6). 699–705. 385 indexed citations
14.
Hsu, Ming‐Ling, et al.. (1997). The anti‐tumor effect of Ganoderma Lucidum is mediated by cytokines released from activated macrophages and T lymphocytes. International Journal of Cancer. 70(6). 699–705. 25 indexed citations
15.
Wu, Chew-Wun, et al.. (1994). Effect of arginase on splenic killer cell activity in patients with gastric cancer. Digestive Diseases and Sciences. 39(5). 1107–1112. 12 indexed citations
16.
Wu, Chew-Wun, et al.. (1992). Functional capacity of a tumor-infiltrating B-cell line: Lymphokine secretion. Immunologic Research. 11(1). 34–41. 2 indexed citations
17.
Ho, Chi‐Kuan, S. L. Law, Hung Chiang, et al.. (1991). Inhibition of microtubule assembly is a possible mechanism of action of mitoxantrone. Biochemical and Biophysical Research Communications. 180(1). 118–123. 14 indexed citations
18.
Ho, Chi‐Kuan, Bor‐Rung Ou, Ching‐Yun Wang, Hour‐Young Chen, & Tsuguo Kuwata. (1989). Differential modulating effects of retinoic acid on interferon antiviral activity. Archives of Virology. 109(1-2). 25–34. 1 indexed citations
19.
Su, Tsung‐Sheng, et al.. (1988). Assessment of HBV persistent infection in an adult population in Taiwan. Journal of Medical Virology. 24(4). 405–412. 4 indexed citations
20.
Wang, Shengyuan, et al.. (1988). The effect of lipopolysaccharide on the production of GM-EA, GM-CSA, and PGE2 by human monocyte-derived lipid-containing macrophages.. PubMed. 16(5). 349–54. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026